drugset / Trial / NCT01199861
Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the effect of treatment with fingolimod on the immune response following seasonal influenza vaccination and tetanus booster injection in patients with relapsing MS.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fingolimod | Small molecule | 0.5 mg | Oral |
| Background | Quadrivalent influenza vaccine | Vaccine | — | Other |
| Background | Tetanus toxoid vaccine | Vaccine | — | Other |